课题基金 / 基金详情

Screening and validation of target molecules involved in mechanism of multi-modality therapy

Screening and validation of target molecules involved in mechanism of multi-modality therapy
多模式治疗机制中靶分子的筛选与验证
批准号:
18590838
负责人:
TAKIGUCHI Yuichi
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

TAKIGUCHI Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background: Substantial evidence has disclosed that some cytotoxic agents have complex activities in influencing signal transduction pathways in cells. Materials and Methods: cDNA microarray analysis was performed after exposing a human squamous cell carcinoma cell line, RERF-LC-AI, to low-dose cisplatin for 5 days. Up-regulated gene expressions were suppressed by small interfering RNA to investigate phenotypic alteration of the cells. Results: Among 30,000 genes screened, 42 genes showed increases or decreases in expression of more than 2-fold in cisplatin treatment. They included genes with functions involved in apoptosis, cell cycle regulation and DNA metabolism/repair. Suppression of the most significantly altered 5 genes by small interfering RNA resulted in partly reduced apoptosis without altering cytotoxicity of cisplatin. Conclusion: Besides direct cytotoxic effects on cells, cisplatin may have indirect effects involving drug resistance, and synergistic effects with other agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ヒト肺癌細胞株を用いたシスプラチンによる遺伝子発現変化とその細胞毒性効果の検討
使用人肺癌细胞系检查顺铂引起的基因表达变化及其细胞毒性作用
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [弥富真理, 滝口裕一, 他]
通讯作者:
Phase II study of weekly irinotecan and cisplatin for refractory or recurtent non-small cell lung cancer
每周一次伊立替康和顺铂治疗难治性或复发性非小细胞肺癌的 II 期研究
DOI: --
发表时间: 2007
期刊: Lung Cancer 58
影响因子: --
作者: [Takiguchi. Y, et. al.]
通讯作者: et. al.
DOI: 10.1002/cncr.21905
发表时间: 2006-06-01
期刊: CANCER
影响因子: 6.2
作者: [Arai, Makoto, Yokosuka, Osamu, Ochiai, Takenori]
通讯作者: Ochiai, Takenori
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer
氨柔比星治疗难治性或复发性小细胞肺癌的 II 期试验
DOI: --
发表时间: 2006
期刊: Journal of Clinical Oncology 24
影响因子: --
作者: [Onoda, S., et al.]
通讯作者: et al.
11
    A novel therapy for lung cancer targeting cancer stem cells.
    • 批准号:
      23591136
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      TAKIGUCHI Yuichi
    • 依托单位:
    Increase in chemo-and radiotherapy and cancer gene therapy by means of suppression of DNA repair genes
    • 批准号:
      14570540
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2002
    • 负责人:
      TAKIGUCHI Yuichi
    • 依托单位:
    Positive interaction between tumor cells and tumor stromal cells for tumor growth.
    • 批准号:
      11670567
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      TAKIGUCHI Yuichi
    • 依托单位:
    海外基金